Delivery Order SPE2DB25D3402-SPE2DB25FUGBZ

Award Date 4/14/25
Potential Completion Date 4/15/25
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,416.39 and has a completion date of February 7, 2024. The contract is for the supply of 4,563,574,052 units of the medication Vyvanse 30 mg capsules in 100s. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $6,759.37. The award is for the supply of 4,567,887,842 units of the medication Vyvanse 30 mg capsules. The contract has an Ultimate Completion Date of April 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,988.41, is a delivery order for 4,567,721,418 units of Vyvanse 30 mg capsules. The contract has a period of performance through March 28, 2025 and is a firm fixed-price contract. AmerisourceBergen is the prime contractor, and there is no set-aside designation for this award. The contract award...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $10,833.45 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,559,778,029 units of Vyvanse 30 mg capsules. The contract has a firm fixed price and an ultimate completion date of January 31, 2023. This award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,453.36 firm fixed-price delivery order is for the supply of 4,566,490,419 units of Vyvanse 30 mg capsules. The contract has an ultimate completion date of November 20, 2024 and was awarded on November 19, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,296.22 firm fixed-price delivery order is for the supply of 4,566,498,336 units of Vyvanse 30 mg capsules. The contract has an ultimate completion date of November 21, 2024 and was awarded on November 20, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,809.54 firm-fixed-price delivery order is for 4,556,517,806 units of the medication Vyvanse 30 mg capsules. The contract has an ultimate completion date of March 10, 2022 and was awarded on March 9, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,085.15, is a Firm Fixed Price delivery order for the supply of 4,567,557,992 units of the prescription drug Vyvanse 30 mg capsules. The contract has an ultimate completion date of March 13, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,283.49 firm fixed-price delivery order is for the supply of 4,565,622,917 units of Vyvanse 40 mg capsules. The contract has an ultimate completion date of August 29, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,510.34 delivery order contract is for the provision of 4,567,984,172 units of Vyvanse 30 mg capsules. The contract is not set aside and is a firm fixed-price delivery order. It is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 held by AmerisourceBergen Drug Corp with the DLA Troop...
  • SPE2DB25D3402
    Indefinite Delivery Contract
  • SPE2DB25D3402-SPE2DB25FUGBZ
    Delivery Order

This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $2,675.40 and is a delivery order with a firm fixed price. It is for the supply of 4,567,909,459 units of Vyvanse 30 mg capsules. The contract has an ultimate completion date of April 15, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 7/14/25, 10:46 AM